Company / Free Cash Flow
MIMEDX GROUP, INC. Free Cash Flow History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$24.8M
FY2023
5-year range
-$19.4M / $24.8M
FY2021-FY2023
Trend
+227.7%
vs FY2022
Sector context
#105 of 147
Health Care
What the data says
Free Cash Flow changed +228% YoY in FY2023, a notable deviation from the 2-year average annual change of -23%.
Based on SEC 10-K filings.
$25M in FY2023.
Improved from -$5M to $25M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 147 in Health CareTop 71% of 147This company $24.8M Sector average $762.7M
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2023, free cash flow increased 227.7% year-over-year.
- Ranks #105 out of 147 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $24.8M | +227.7% |
| FY2022 | -$19.4M | -273.2% |
| FY2021 | -$5.2M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026